Clinical Case Vignette Series™: 42nd Annual Miami Breast Cancer Conference®

Release Date: May 30, 2025

Expiration Date: May 30, 2026

Activity Overview

Breast cancer encompasses a diverse and complex group of diseases, with ongoing advances in detection, diagnosis, and multimodal treatment reshaping care. As our understanding of tumor biology deepens and standards of care evolve, so do the clinical questions and challenges faced by practitioners. Focused, case-based education is essential to support the integration of the latest evidence into everyday practice.

This Clinical Case Vignette Series™ offers a dynamic review of key insights from the 42nd Annual Miami Breast Cancer Conference®, which took place in March 2025. Through engaging expert interviews, the program highlights real-world clinical scenarios and explores how emerging data and evidence-based strategies are improving outcomes. Designed for clinicians who missed the live event—or those seeking to reinforce their learning—this activity delivers timely, practice-relevant education on the most pressing issues in breast cancer management.

Target Audience

This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Describe how to use validated genomic and molecular biomarkers and appropriate imaging techniques to enhance tumor evaluation and inform treatment decisions for patients with breast cancer
• Apply advances in surgical and radiation therapy options to improve breast cancer patient outcomes, emphasizing a multidisciplinary approach
• Integrate clinical trial evidence on established and emerging systemic therapies for early-stage and advanced breast cancers
• Personalize systemic treatment strategies for early-stage or advanced/metastatic breast cancer based on patient-specific factors, tumor characteristics, efficacy, safety data, and evolving guidelines
• Review clinical trials of novel therapies for eligible patients with breast cancer
• Implement multidisciplinary strategies to prevent, manage, and mitigate treatment-related adverse effects in patients with breast cancer, ensuring optimal outcomes and quality of life